Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

LUCARA SHARE CAPITAL AND VOTING RIGHTS UPDATE

VANCOUVER, BC, August 31, 2023 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) reports the following in accordance with the Swedish Financial Instruments Trading Act: The Company issued 450,000 common shares to its largest shareholder, Nemesia S.a.r.l. as consideration for providing a Liquidity Guarantee of up to $15.0 million in aggregate, as described in the Company’s news release from August 23, 2023. The number of issued and outstanding shares of the Company has increased to 455,028,873 common shares with voting rights as at

Dentalum Operations AB (publ) Interim report second quarter and January-June 2023

Second quarter April-June 2023 · Capital structure was strengthened by a shareholders’ contribution in the amount of SEK 141 million following a share issue of 153 million in Dentalum Group AB. · Reported net revenue in the second quarter was to SEK 125.2 million (105.4) and total revenues SEK 126.5 million (105.7). · The increase in quarterly revenue compared to the same quarter prior year, was driven by acquisitions of seven dental clinics, acquired since the same quarter in 2022, albeit some clinics faced a general decline in revenues. · Consolidated EBITDA was SEK 20.3

Noble Corporation plc announces changes to its share capital including share repurchases for the month of August 2023

SUGAR LAND, Texas, Aug. 31, 2023 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces changes to its share capital. During the month of August, Noble repurchased approximately $10 million of A ordinary shares under its previously announced share repurchase plan at a weighted average price of approximately $50.62 per share and a total of 197,477 repurchased A ordinary shares were cancelled.   During the period since July 31, 2023, 4,153,236 new A ordinary shares each with a nominal value of USD 0.00001 have been issued.   4,140,547 new A ordinary

The Board of Directors in FlexQube has resolved on a previously announced fully guaranteed rights issue of approximately SEK 75 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES PURSUANT TO APPLICABLE LAW. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Mölndal, August 31, 2023 The Board of Directors in FlexQube AB (“FlexQube” or the “Company”) announced

Nordea Bank Abp: Repurchase of own shares on 31.08.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares31.08.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 31.08.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |32,968 |10.21 |336,510.97

DanCann Pharma A/S Completes Issuance (3) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 31 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today, on 31 August 2023, issued a total of 2,689,950 new shares of nominally DKK 0.0375 each by conversion of debt in the total amount of DKK 450,000 under the instrument issued as of 13 July 2023.As set out in press release published on 17 July 2023, the Company has issued a total of 378 convertible debt instruments, each of an amount of DKK 50,000, equal to an aggregate amount of DKK 18,900,000, and 8,190,000 warrants to

Dentalum has a positive view on refinancing possibilities

Dentalum Operations AB (publ) (“Dentalum Operations” or the “Company”) has, since the execution of the communicated share issue of SEK 153 million in Dentalum Group AB, continued its process to refinance the Company´s Senior bond, maturing on October 2, 2023 (“the Bond”). As a result, the Company has reached advanced discussions with banks and an agreement is expected to be signed before the maturity of the Bond. In parallel, a possibility to extend instead of refinance the Bond, is being assessed, should an agreement for bank financing not materialize within the coming weeks. Should none

Vestas has signed a conditional agreement for an onshore wind power project above 1 GW in the USA

Vestas Wind Systems A/S, Aarhus, 31 August 2023Company Announcement No. 15/2023 Vestas has signed a conditional agreement for the supply of turbines for an onshore project in the USA with a capacity above Vestas’ current disclosure threshold of 1 GW. If and when the agreement translates into a firm and unconditional order, Vestas will disclose this in a company announcement in accordance with the company’s disclosure policy. Contact detailsVestas Wind Systems A/S, Denmark Daniel Patterson, Vice PresidentInvestor RelationsTel: +45 2669 2725

Multiconsult ASA - Share buyback

Multiconsult ASA (OSE: MULTI) announced on 5 July 2023 a non-discretionary agreement with ABG Sundal Collier for the repurchase of up to 500 000 of its ordinary shares in the market with employee share saving programme and executive management bonus schemes, or as consideration in connection with acquisitions.From 23 - 31 August 2023, Multiconsult ASA has purchased a total of 8 441 own shares at Oslo Børs at an average price of NOK 139.2320 per share.  Aggregated overview of transactions per day: Overview oftransactionsDate Aggregated daily Weighted average Total

Successful 5-year Eurobond issue for Mölnlycke

Gothenburg, 31 August 2023: Mölnlycke, a world-leading medtech company, has successfully raised EUR 400M in the corporate bond market under its Euro Medium Term Note (EMTN) programme. The bond has a 5-year tenor with an annual fixed coupon of 4.25% corresponding to mid swaps of +1.18 percentage points.The bond was more than 3.5 times oversubscribed with an orderbook of over EUR 1,400M at its peak. There was strong and widespread demand from leading investors in Germany, Austria and Switzerland 40%, Nordics 27%, UK & Ireland 23%, France  6%, Other 4%. Asset Managers represented 90% of

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 31 August 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 31 August 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)Number

Veg of Lund announces outcome of rights issue

Veg of Lund AB (publ) (“Veg of Lund” or the “Company”) today announces the outcome of the rights issue of units consisting of shares that was announced on 4 August 2023 (the “Rights Issue”). The Rights Issue has been subscribed to a total of approximately 75 percent, of which approximately 45.54 percent was subscribed with unit rights, approximately 1.56 percent was subscribed without unit rights and approximately 27.87 percent was subscribed by underwriters. Through the Rights Issue, the Company will receive approximately MSEK 17.8 before issue costs.NOT FOR RELEASE, PUBLICATION OR

Clean Industry Solutions Holding Europe AB (publ) carries out a rights issue of shares of approximately SEK 25.5 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CLEAN INDUSTRY SOLUTIONS HOLDING EUROPE AB (PUBL). SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT.  The Board of Directors of Clean Industry Solutions Holding Europe AB (publ) (“Clean Industry Solutions” or the “Company”)

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 31 August 2023 the Company bought 140,121 of its own shares for cancellation at a price of 209.389 pence per share.  The Company's issued ordinary share capital is 565,415,408 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 479,785,860. The above figure (479,785,860) may be used by shareholders as the denominator for the

Resqunit AB publishes Half Year Report H1-2023

Resqunit AB (publ) ("Resqunit") August 31st, 2023, at 18.00 CET - publishes Half Year Report H1-2023First half year 2023 - compared to first half year 2022 Group revenue have been limited in both years.Operating profit amounted to -4 558 675 SEK (-5 131 108 SEK).Earnings per share -0,40 SEK (-0,48 SEK).  Key figures (SEK) 2023 Group 2022 GroupNet sales, SEK 587 982 43 88Operating profit, SEK -4 558 675 -5 131 108Earnings per share -0,40 -0,48Equity per share -0,24 0,54Outstanding shares

Interim Financial Report – first six months of 2023 (Q2 2023)

Company announcement fromSGL Group ApS 31 August 2023                            Company announcement no. 4                                           Today, SGL Group ApS has published its Interim Financial Report for the first six months of 2023 (Q2 2023). SGL Group - Pro forma interim financial results To ensure like-for-like comparability of financial performance following the acquisition of Scan Global Logistics by CVC Funds on 23 May 2023, we present Pro Forma Interim Financial Results (refer to pages 3-11 in the interim financial report) comprising financial

Antioxidants stimulate blood flow in tumours

Vitamin C and other antioxidants stimulate the formation of new blood vessels in lung cancer tumours, a new study from Karolinska Institutet published in The Journal of Clinical Investigation shows. The discovery corroborates the idea that dietary supplements containing antioxidants can accelerate tumour growth and metastasis.“We’ve found that antioxidants activate a mechanism that causes cancer tumours to form new blood vessels, which is surprising, since it was previously thought that antioxidants have a protective effect,” says study leader Martin Bergö, professor at the Department of

CHANGE IN NUMBER OF SHARES AND VOTES IN MODERN TIMES GROUP MTG AB

Modern Times Group MTG AB (MTG) today announces that as of 31 August 2023, the total number of shares in the company amounts to 131,668,727, and the total number of votes in the company amounts to 136,579,685.On 17 May 2023, the Annual General Meeting of MTG resolved on a reduction of the share capital by SEK 32,600,000 by way of cancellation of 6,520,000 Class B shares repurchased by MTG under its share repurchase programs during the period between 20 June 2022 and 26 April 2023. The reduction of the share capital by way of cancellation of repurchased shares was approved by the relevant

AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma

AcuCort AB has today signed a partnership agreement for Sweden, Norway, Denmark and Finland with Unimedic Pharma. The agreement means that Unimedic will be responsible for sales and marketing of AcuCort's oral film Zeqmelit® in these countries.With the agreement, AcuCort enters the commercialization phase that the company has been preparing for a long time. Previously, the company's oral film Zeqmelit® has received approval from pharmaceutical authorities in Sweden, Denmark, Norway and Finland, which allows for a commercial venture in these countries. "The agreement with Unimedic Pharma

Bodycote plc - Total Voting Rights

BODYCOTE PLC (the "Company") Total Voting Rights 31 August 2023 In conformity with DTR5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 191,456,172 ordinary shares with a nominal value of 17 3/11th pence each ("Ordinary Shares"), with voting rights.  The Company does not hold any shares in Treasury. Therefore, the total number of Ordinary Shares with voting rights is 191,456,172. The above figure of 191,456,172 Ordinary Shares may be used by shareholders in the Company as the "

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change.In August 2023, at the request of shareholders, 600,000 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 156,189,281.9. The total number of registered shares in the company amounts to 576,343,778 shares of

DanCann Pharma A/S publishes Q2-2023 report

COPENHAGEN, Denmark, 31 August 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the second quarter of 2023. The Q2-2023 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q2-2023: 01/01/23 - 30/06/23 01/01/22 - 30/06/22 01/04/23 - 30/06/23 01/04/22 - 30/06/22 01/01/22 - 31/12/22Net sales

Bittium Corporation: SHARE REPURCHASE 31.8.2023

Bittium Corporation  ANNOUNCEMENT  31.8.2023 Bittium Corporation: SHARE REPURCHASE 31.8.2023 In the Helsinki Stock Exchange Trade date           31.8.2023Bourse trade         BuyShare                  BITTIAmount             998 SharesAverage price/ share    4,0150 EURTotal cost            4 006,97 EUR Bittium Corporation now holds a total of 161 929 sharesincluding the shares repurchased on 31.8.2023 On behalf of Bittium Corporation Nordea Bank Oyj

There are no items matching the current filter
There are no more items matching the current filter
Back to top